Effects of a minimum interval immunization schedule for diphtheria and tetanus toxoids and acellular pertussis vaccination during a pertussis outbreak

Archives of Pediatrics and Adolescent Medicine

Volumn 163, Issue 5, 2009, Pages 417-421

  Bronson Lowe, Daniel ^a,b   Anderson, Shoana M ^a  

^a ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^b CARLE FOUNDATION HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

AGE DISTRIBUTION; ARTICLE; CHILD; COHORT ANALYSIS; EPIDEMIC; FEMALE; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; SOCIOECONOMICS; STATISTICAL ANALYSIS; UNITED STATES;

ARIZONA; COHORT STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PNEUMOCOCCAL VACCINES; POLIOVIRUS VACCINE, INACTIVATED; RETROSPECTIVE STUDIES; WHOOPING COUGH;

EID: 66149156449     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2009.53     Document Type: Article

References (15)

1. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155-2163.
2. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine- Preventable Diseases. 10th ed. Washington, DC: Public Health Foundation; 2008:81-99. http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm. Accessed September 13, 2008.
3. Güriş D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28(6):1230-1237.
4. Edwards K, Decker M. Pertussis vaccine. In: Plotkin S, Orenstein W, eds. Vaccines. 3rd ed. St Louis: WB Saunders Co; 2004:471-528.
5. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 years: United States, 2008.MMWRMorb Mortal Wkly Rep. 2008;57(1):Q-1-Q-4. http://www.cdc.gov/mmwr/PDF/wk/mm5701.pdf. Accessed September 13, 2008.
6. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA. 2003;290(22):2968-2975.
7. Centers for Disease Control and Prevention. Guidelines for the control of pertussis outbreaks. Atlanta, GA: Centers for Disease Control and Prevention; 2000. http://www.cdc.gov/vaccines/pubs/pertussis-guide/guide.htm. Accessed September 13, 2008.
8. Jones O, Sankar KN. Audit of outcome of super-accelerated hepatitis B vaccination schedule in a genitourinary medicine clinic. Int J STD AIDS. 2005;16(9):636-637.
9. Macdonald V, Dore GJ, Amin J, van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007;4(1):27-30.
10. Centers for Disease Control and Prevention. Programs and tools: Vaccines for Children Program (VFC). http://www.cdc.gov/vaccines/programs/vfc/default. htm. Accessed September 13, 2008.
11. Shinall MC Jr, Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics. 2008;122(5):1021-1026.
12. Centers for Disease Control and Prevention. Program annual report and progress assessments. http://www2a.cdc.gov/nip/irar/grantee/granteeinfo. asp#grptg. Accessed December 16, 2008.
13. Centers for Disease Control and Prevention. Estimated vaccination coverage with individual vaccines and selected vaccination series before 13 months of age by state and local area: US National Immunization Survey, 2006. http://www2a.cdc.gov/nip/coverage/nis/nis-iap.asp?fmt=v&rpt= tab07-13mo-iap&qtr=Q1/2006-Q4/2006. Accessed September 11, 2008.
14. Khare M, Piccinino L, Barker LE, Linkins RW. Assessment of immunization registry databases as supplemental sources of data to improve ascertainment of vaccination coverage estimates in the National Immunization Survey. Arch Pediatr Adolesc Med. 2006;160(8):838-842.
15. Mahon BE, Shea KM, Dougherty NN, Loughlin AM. Implications for registry-based vaccine effectiveness studies from an evaluation of an immunization registry: a cross-sectional study. BMC Public Health. 2008;8:160. doi:10.1186/1471-2458-8-160.